Insider Trading Alert - SRDX, HMST And FEYE Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, June 9, 2015, 89 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $352.00 to $81,483,250.00.

Highlighted Stocks Traded by Insiders:

SurModics (SRDX) - FREE Research Report

Stich Joseph J., who is VP, Bus Ops & GM, IVD at SurModics, sold 1,000 shares at $23.84 on June 9, 2015. Following this transaction, the VP, Bus Ops & GM, IVD owned 23,144 shares meaning that the stake was reduced by 4.14% with the 1,000-share transaction.

The shares most recently traded at $23.71, down $0.13, or 0.54% since the insider transaction. Historical insider transactions for SurModics go as follows:

  • 4-Week # shares bought: 1,500
  • 4-Week # shares sold: 2,162
  • 12-Week # shares bought: 1,500
  • 12-Week # shares sold: 13,824
  • 24-Week # shares bought: 1,500
  • 24-Week # shares sold: 14,824

The average volume for SurModics has been 73,900 shares per day over the past 30 days. SurModics has a market cap of $308.0 million and is part of the health care sector and drugs industry. Shares are up 7.1% year-to-date as of the close of trading on Tuesday.

SurModics, Inc. provides surface modification and in vitro diagnostic technologies to the healthcare industry. The company operates through two segments, Medical Device and In Vitro Diagnostics. The company has a P/E ratio of 25.2. Currently, there are 3 analysts who rate SurModics a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SRDX - FREE

TheStreet Quant Ratings rates SurModics as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and reasonable valuation levels. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full SurModics Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

HomeStreet (HMST) - FREE Research Report

Iseman Jay C, who is EVP - Chief Credit Officer at HomeStreet, sold 816 shares at $23.05 on June 9, 2015. Following this transaction, the EVP - Chief Credit Officer owned 38,144 shares meaning that the stake was reduced by 2.09% with the 816-share transaction.

The shares most recently traded at $24.22, up $1.17, or 4.83% since the insider transaction. Historical insider transactions for HomeStreet go as follows:

  • 4-Week # shares bought: 3,220
  • 12-Week # shares bought: 3,220
  • 12-Week # shares sold: 5,000
  • 24-Week # shares bought: 9,220
  • 24-Week # shares sold: 5,000

The average volume for HomeStreet has been 163,000 shares per day over the past 30 days. HomeStreet has a market cap of $511.7 million and is part of the financial sector and banking industry. Shares are up 33.26% year-to-date as of the close of trading on Tuesday.

HomeStreet, Inc., together with its subsidiaries, provides various financial services primarily in the Pacific Northwest, California, and Hawaii. The company operates in two segments, Commercial and Consumer Banking, and Mortgage Banking. The stock currently has a dividend yield of 0.62%. The company has a P/E ratio of 12.0. Currently, there are 4 analysts who rate HomeStreet a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on HMST - FREE

TheStreet Quant Ratings rates HomeStreet as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and attractive valuation levels. However, as a counter to these strengths, we find that we feel that the company's cash flow from its operations has been weak overall. Get the full HomeStreet Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

FireEye (FEYE) - FREE Research Report

King Alexa, who is SVP and General Counsel at FireEye, sold 27,063 shares at $50.31 on June 9, 2015. Following this transaction, the SVP and General Counsel owned 328,477 shares meaning that the stake was reduced by 7.61% with the 27,063-share transaction.

The shares most recently traded at $51.34, up $1.03, or 2% since the insider transaction. Historical insider transactions for FireEye go as follows:

  • 4-Week # shares sold: 388,667
  • 12-Week # shares sold: 393,667
  • 24-Week # shares sold: 419,959

The average volume for FireEye has been 5.8 million shares per day over the past 30 days. FireEye has a market cap of $8.0 billion and is part of the technology sector and computer software & services industry. Shares are up 60.37% year-to-date as of the close of trading on Tuesday.

FireEye, Inc., together with its subsidiaries, provides cybersecurity solutions for detecting, preventing, and resolving cyber-attacks. Currently, there are 11 analysts who rate FireEye a buy, 1 analyst rates it a sell, and 10 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on FEYE - FREE

TheStreet Quant Ratings rates FireEye as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income and feeble growth in its earnings per share. Get the full FireEye Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Trump, China Trade, Target and Las Vegas Casinos - 5 Things You Must Know

Trump, China Trade, Target and Las Vegas Casinos - 5 Things You Must Know

Stocks Move Lower on Trade Fears and 4 Other Stories You Must Know Wednesday

Stocks Move Lower on Trade Fears and 4 Other Stories You Must Know Wednesday

Global Rally Stalls as Trump Doubts North Korea Summit, Questions China Trade

Global Rally Stalls as Trump Doubts North Korea Summit, Questions China Trade

Target Slumps After Q1 Earnings Miss as Comparable Sales Slow, Traffic Improves

Target Slumps After Q1 Earnings Miss as Comparable Sales Slow, Traffic Improves

Pound Slides as Inflation Slows, Doubts Grow Over Bank of England Rate Hikes

Pound Slides as Inflation Slows, Doubts Grow Over Bank of England Rate Hikes